evaluated the tumor-promoting effects of CXCL12 derived from cancer-associated fibroblasts and found that inhibition of CXCL12 production decreases the invasiveness of gastric cancer cells via the suppression of integrin β1/FAK signaling. This evidence concerns the gene CXCL12 and neoplasm.